Main Page: Difference between revisions

From W8MD weight loss and sleep centers
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
[[File:W8MD-Team.jpg|800px|left]]
The W8MD' [[W8MD_Weight_Loss,_Sleep_and_Medspa|physician weight loss]] program is a clinically proven, evidence-based program that helps patients [[lose weight]] and maintain the weight with an ongoing maintenance plan for [[medical-weight-loss|adults]] and [[childhood obesity|children]]. [[W8MD_Weight_Loss,_Sleep_and_Medspa|Learn more...]]
The W8MD' [[W8MD_Weight_Loss,_Sleep_and_Medspa|physician weight loss]] program is a clinically proven, evidence-based program that helps patients [[lose weight]] and maintain the weight with an ongoing maintenance plan for [[medical-weight-loss|adults]] and [[childhood obesity|children]]. [[W8MD_Weight_Loss,_Sleep_and_Medspa|Learn more...]]
==Tirzepatide / Semaglutide for weight loss ==
[[Tirzepatide]], available as [[Zepbound]] and [[Mounjaro]], is a weekly injection that helps control blood sugar levels and was approved for use in treating type 2 diabetes by the FDA in May 2022. Distinguished from drugs such as [[Ozempic]] and [[Wegovy]] both of which have [[Semaglutide]], [[Zepbound]], [[Mounjaro]] with active ingredient of [[Tirzepatide]] is a combination of a glucagon-like peptide-1 (GLP-1) receptor agonist, used for diabetes and weight loss treatment, and a glucose-dependent insulinotropic polypeptide (GIP), a hormone that aids insulin release after eating.
Tirzepatide became so popular that it was listed by the FDA as one of nearly 200 drugs experiencing a supply shortage, along with [[Wegovy]], [[Ozempic]] (semaglutide), and [[Trulicity]] (dulaglutide), which are sometimes prescribed for off-label [[weight loss]] use. [[Mounjaro|Learn more...]]
{|style="border-spacing:8px;margin:0px -8px"
{|style="border-spacing:8px;margin:0px -8px"
|class="MainPageBG" style="width:55%;border:1px solid #cef2e4;background-color:#f5fffa;vertical-align:top;color:#000"|
|class="MainPageBG" style="width:55%;border:1px solid #cef2e4;background-color:#f5fffa;vertical-align:top;color:#000"|
Line 25: Line 31:
If insurance does not cover the brands, W8MD offers discounted '''[[weight loss injections]]'''  
If insurance does not cover the brands, W8MD offers discounted '''[[weight loss injections]]'''  
===Semaglutide & Tirzepatide: Proven solutions starting at just $125.00 biweekly!===
===Semaglutide & Tirzepatide: Proven solutions starting at just $125.00 biweekly!===
[[Weight loss injections|Learn more...]]</h3>
[[Weight loss injections|Learn more...]]
|}
|}
<!-- Start of right-column -->
<!-- Start of right-column -->
Line 51: Line 57:
In October 2022, the Food and Drug Administration (FDA) granted Mounjaro, a diabetes drug, a fast-track designation for weight loss, leading to speculation that it will be approved for weight loss use this year due to its promising results in clinical trials.
In October 2022, the Food and Drug Administration (FDA) granted Mounjaro, a diabetes drug, a fast-track designation for weight loss, leading to speculation that it will be approved for weight loss use this year due to its promising results in clinical trials.
[[File:Weight-loss-success-stories.jpeg|thumb|Weight loss success stories]]
[[File:Weight-loss-success-stories.jpeg|thumb|Weight loss success stories]]
==Zepbound / Mounjaro (Tirzepatide) weight loss results==
[[Tirzepatide]], available as [[Zepbound]] and [[Mounjaro]], is a weekly injection that helps control blood sugar levels and was approved for use in treating type 2 diabetes by the FDA in May 2022. Distinguished from drugs such as [[Ozempic]] and [[Wegovy]] both of which have [[Semaglutide]], [[Zepbound]], [[Mounjaro]] with active ingredient of [[Tirzepatide]] is a combination of a glucagon-like peptide-1 (GLP-1) receptor agonist, used for diabetes and weight loss treatment, and a glucose-dependent insulinotropic polypeptide (GIP), a hormone that aids insulin release after eating.


==Wegovy (Semaglutide) injections==
Although it has yet to be approved by the FDA for [[weight loss]], some doctors, including '''W8MD weight loss physicians''', prescribe it for off-label use to help with weight loss in patients without type 2 diabetes. In fact, Mounjaro became so popular that it was listed by the FDA as one of nearly 200 drugs experiencing a supply shortage, along with [[Wegovy]], [[Ozempic]] (semaglutide), and [[Trulicity]] (dulaglutide), which are sometimes prescribed for off-label [[weight loss]] use. [[Mounjaro|Learn more...]]
[[File:W8md-protein-bar.jpeg|thumb|Weight loss supplements]]
[[File:W8md-protein-bar.jpeg|thumb|Weight loss supplements]]
==3 things wrong with our diet==
==3 things wrong with our diet==
Line 70: Line 72:
* Many convenient locations
* Many convenient locations
* New - Tele-visits after fist visit. [[W8md-advantage|Learn more...]]
* New - Tele-visits after fist visit. [[W8md-advantage|Learn more...]]
</h2>
 
=='''Amazing success stories'''==
=='''Amazing success stories'''==
I started with Dr. Tumpati and W8MD in August 2014. I weighed 212 pounds. I am a five feet tall woman, at the time I was 56 years old. I was depressed, my cholesterol, blood pressure, and blood sugar were all elevated, and I was altogether miserable. At this writing, November 2019, I have lost and maintained 100 pounds. All my blood levels are now normal. I have energy, vitality, and if I say so myself, I look AMAZING!
I started with Dr. Tumpati and W8MD in August 2014. I weighed 212 pounds. I am a five feet tall woman, at the time I was 56 years old. I was depressed, my cholesterol, blood pressure, and blood sugar were all elevated, and I was altogether miserable. At this writing, November 2019, I have lost and maintained 100 pounds. All my blood levels are now normal. I have energy, vitality, and if I say so myself, I look AMAZING!